Engineers Gate Manager’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Buy |
133,014
+8,450
| +7% | +$79.3K | 0.02% | 998 |
|
|
2025
Q1 | $886K | Sell |
124,564
-23,603
| -16% | -$168K | 0.01% | 1132 |
|
|
2024
Q4 | $1.73M | Buy |
148,167
+96,410
| +186% | +$1.12M | 0.03% | 693 |
|
|
2024
Q3 | $1.06M | Sell |
51,757
-9,771
| -16% | -$201K | 0.02% | 952 |
|
|
2024
Q2 | $1.38M | Buy |
+61,528
| New | +$1.38M | 0.03% | 737 |
|
|
2023
Q4 | – | Sell |
-23,349
| Closed | -$738K | – | 2155 |
|
|
2023
Q3 | $738K | Buy |
23,349
+16,143
| +224% | +$510K | 0.03% | 882 |
|
|
2023
Q2 | $294K | Sell |
7,206
-37,881
| -84% | -$1.54M | 0.01% | 1312 |
|
|
2023
Q1 | $1.68M | Buy |
45,087
+6,520
| +17% | +$243K | 0.07% | 371 |
|
|
2022
Q4 | $1.35M | Buy |
38,567
+10,109
| +36% | +$353K | 0.08% | 329 |
|
|
2022
Q3 | $1.59M | Buy |
+28,458
| New | +$1.59M | 0.1% | 252 |
|
|
2021
Q1 | – | Sell |
-15,150
| Closed | -$824K | – | 2033 |
|
|
2020
Q4 | $824K | Sell |
15,150
-30,288
| -67% | -$1.65M | 0.04% | 683 |
|
|
2020
Q3 | $903K | Buy |
+45,438
| New | +$903K | 0.04% | 671 |
|
|
2020
Q2 | – | Sell |
-24,539
| Closed | -$300K | – | 1896 |
|
|
2020
Q1 | $300K | Buy |
+24,539
| New | +$300K | 0.02% | 1040 |
|